Cemil Kayali1, Taskin Altay1, Firat Ozan2, Serkan Sozkesen3, Kamil Yamak1. 1. Department of Orthopedics and Traumatology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey. 2. Department of Orthopedics and Traumatology, Kayseri Training and Research Hospital, Kayseri, Turkey. 3. Department of Orthopedics and Traumatology, Ağrı State Hospital, Ağrı, Turkey.
Abstract
BACKGROUND: Bisphosphonates (BPs) are one of the most commonly used agents in the treatment of post-menopausal osteoporosis and other metabolic bone diseases. METHODS: Between 2010 and 2015, data of 22 osteoporotic women with femoral fractures due to low-energy trauma who received BPs previously were analysed. RESULTS: The mean duration of BP therapy was 7.6 years. The mean duration of union was 7.4 months. Five patients had non-union. Stress reaction was observed in the contralateral femur in 11 patients. CONCLUSION: Radiographic studies should be performed on a regular basis to prevent atypical femoral fractures in patients on long-term BP therapy.
BACKGROUND:Bisphosphonates (BPs) are one of the most commonly used agents in the treatment of post-menopausal osteoporosis and other metabolic bone diseases. METHODS: Between 2010 and 2015, data of 22 osteoporoticwomen with femoral fractures due to low-energy trauma who received BPs previously were analysed. RESULTS: The mean duration of BP therapy was 7.6 years. The mean duration of union was 7.4 months. Five patients had non-union. Stress reaction was observed in the contralateral femur in 11 patients. CONCLUSION: Radiographic studies should be performed on a regular basis to prevent atypical femoral fractures in patients on long-term BP therapy.
Authors: Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte Journal: J Bone Miner Res Date: 2013-10-01 Impact factor: 6.741
Authors: B A Lenart; A S Neviaser; S Lyman; C C Chang; F Edobor-Osula; B Steele; M C H van der Meulen; D G Lorich; J M Lane Journal: Osteoporos Int Date: 2008-12-09 Impact factor: 4.507
Authors: Matthijs P Somford; Frits W Draijer; Bregje J W Thomassen; Pascale M Chavassieux; Georges Boivin; Socrates E Papapoulos Journal: J Bone Miner Res Date: 2009-10 Impact factor: 6.741
Authors: Adel Ebrahimpour; Mehrdad Sadighi; Amir Human Hoveidaei; Mohammadreza Chehrassan; Reza Minaei; Hamed Vahedi; Sm Javad Mortazavi Journal: Arch Bone Jt Surg Date: 2021-05